A foundational in vivo platform for predicting human health outcomes
Rodents remain the workhorse of preclinical drug development, yet often fail to predict human clinical outcomes. Existing alternatives are similarly constrained. Cells in culture cannot recapitulate whole-organism physiology, and larger mammals cannot be studied at comparable throughput. Here we present a scalable, information-dense platform that can predict a drug's long-term human clinical…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
